For the Inventor, By the Inventor

Enter assignee name

Institute Curie

USPTO Granted Patents = 11

% Expired Patents = 72.7

Forward Citations = 27

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Jean-Louis Viovy (4 out of 24 patents)

Valessa Barbier (3 out of 3 patents)

Eric Tartour (2 out of 5 patents)

4. Angelita Rebollo Garcia (2 out of 6 patents)

5. Fariba Nemati (2 out of 5 patents)

6. Didier Decaudin (2 out of 6 patents)

7. Ludger Johannes (2 out of 13 patents)

8. Bruno Goud (2 out of 7 patents)

9. Wolf Herve Fridman (2 out of 3 patents)

10. Laurence Zitvogel (1 out of 24 patents)

11. Sebastian Amigorena (1 out of 12 patents)

12. Jesus Maria Fominaya Gutierrez (1 out of 3 patents)

13. Jeronimo Bravo Sicilia (1 out of 3 patents)

14. Aurélie Thuleau (1 out of 2 patents)

15. Isabelle Fromantin (1 out of 2 patents)

11 patents: Sort by Forward Citations

1. 11439724 - Device for adsorbing odours (2022-09-13),

2. 9658189 - Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomena (2017-05-23),

3. 9364514 - Anti-tumor adjuvant therapy (2016-06-14),

4. 9353155 - Cell-penetrating peptides (2016-05-31),

5. 9347915 - Non-thermosensitive medium for analyzing species in a channel and for minimizing absorption and/or electroosomosic phenomena (2016-05-24),

6. 8975328 - Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomena (2015-03-10),

7. 8852612 - Universal carrier for targeting molecules to Gb3 receptor expressing cells (2014-10-07),

8. 8545770 - Method for improving the bonding properties of microstructured substrates, and devices prepared with this method (2013-10-01),

9. 7632514 - Universal carrier for targeting molecules to Gb3 receptor expressing cells (2009-12-15),

10. 7625573 - Sensitization process for antigen-presenting cells and means for implementing the process (2009-12-01),

11. 7115608 - Pyridinone and pyridinethione derivatives having HIV inhibiting properties (2006-10-03),

Company Overview

Institute Curie is a leading French research institution dedicated to cancer treatment and research. Located in Paris, it specializes in innovative therapies, including personalized medicine and immunotherapy, aimed at improving patient outcomes. The institute combines cutting-edge scientific research with clinical applications, fostering collaboration among researchers, clinicians, and industry partners. Its commitment to advancing cancer care positions it as a pivotal player in the global fight against cancer, contributing to both local and international health initiatives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#346 in Paris

#1,584 in France

#51,801 in the World

Institute Curie

Forward Citations = 27

33 inventors:

Jean-Louis Viovy (4 out of 24 patents)

Valessa Barbier (3 out of 3 patents)

Eric Tartour (2 out of 5 patents)

4. Angelita Rebollo Garcia (2 out of 6 patents)

5. Fariba Nemati (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Institute Curie. Retrieved from https://idiyas.com/company/institute-curie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…